Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers Journal Article


Authors: Karam, I.; Yao, M.; Heron, D. E.; Poon, I.; Koyfman, S. A.; Yom, S. S.; Siddiqui, F.; Lartigau, E.; Cengiz, M.; Yamazaki, H.; Hara, W.; Phan, J.; Vargo, J. A.; Lee, V.; Foote, R. L.; Harter, K. W.; Lee, N. Y.; Sahgal, A.; Lo, S. S.
Article Title: Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers
Abstract: Aim: To provide a multi-institutional description of current practices of stereotactic body radiotherapy (SBRT) for head and neck cancer. Materials & methods: 15 international institutions with significant experience in head and neck SBRT were asked to complete a questionnaire covering clinical and technical factors. Results: SBRT is used 10-100% of the time for recurrent primary head and neck cancer, and 0-10% of the time in newly diagnosed disease. Five centers use a constraint for primary disease of 3-5 cm and 25-30 cc. Nine institutions apply a clinical target volume expansion of 1-10 mm and 14 use a planning target volume margin of 1-5 mm. Fractionation regimens vary between 15 and 22 Gy in 1 fraction to 30-50 Gy in 5 or 6 fractions. The risk of carotid blowout quoted in the re-irradiation setting ranges from 3 to 20%. Conclusion: There is considerable heterogeneity in patient selection and techniques in head and neck SBRT practice among experienced centers. © 2016 Future Medicine Ltd.
Keywords: head and neck cancer; sbrt; ablation; stereotactic; patterns of practice
Journal Title: Future Oncology
Volume: 13
Issue: 7
ISSN: 1479-6694
Publisher: Future Medicine  
Date Published: 2017-03-01
Start Page: 603
End Page: 613
Language: English
DOI: 10.2217/fon-2016-0403
PROVIDER: scopus
PUBMED: 27842456
DOI/URL:
Notes: Article -- Export Date: 2 March 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nancy Y. Lee
    871 Lee